Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1991 1
1992 2
1993 1
1994 2
1996 3
1997 5
1998 7
1999 11
2000 6
2001 16
2002 16
2003 13
2004 17
2005 23
2006 20
2007 18
2008 20
2009 25
2010 35
2011 38
2012 39
2013 40
2014 46
2015 40
2016 40
2017 41
2018 35
2019 55
2020 73
2021 58
2022 63
2023 58
2024 59
2025 47
2026 54

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

912 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY.
Kang YK, Kim HD, Yook JH, Park YK, Lee JS, Kim YW, Kim JY, Ryu MH, Rha SY, Chung IJ, Kim IH, Oh SC, Park YS, Cheong JH, Jeong O, Heo MH, Kim HK, Park C, Yoo CH, Kang SY, Zang DY, Jang YJ, Sul JY, Kim JG, Kim BS, Beom SH, Hwang JE, Ryu SW, Kook MC, Ryoo BY, Kim H, Yoo MW, Lee NS, Lee SH, Noh SH. Kang YK, et al. Among authors: heo mh. J Clin Oncol. 2024 Sep 1;42(25):2961-2965. doi: 10.1200/JCO.23.02167. Epub 2024 Jul 12. J Clin Oncol. 2024. PMID: 38996201 Clinical Trial.
PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer.
Kang YK, Yook JH, Park YK, Lee JS, Kim YW, Kim JY, Ryu MH, Rha SY, Chung IJ, Kim IH, Oh SC, Park YS, Son T, Jung MR, Heo MH, Kim HK, Park C, Yoo CH, Choi JH, Zang DY, Jang YJ, Sul JY, Kim JG, Kim BS, Beom SH, Cho SH, Ryu SW, Kook MC, Ryoo BY, Kim HK, Yoo MW, Lee NS, Lee SH, Kim G, Lee Y, Lee JH, Noh SH. Kang YK, et al. Among authors: heo mh. J Clin Oncol. 2021 Sep 10;39(26):2903-2913. doi: 10.1200/JCO.20.02914. Epub 2021 Jun 16. J Clin Oncol. 2021. PMID: 34133211 Free PMC article. Clinical Trial.
When Liver Slices Meet Single-cell Technology.
Heo MJ, Kim KH. Heo MJ, et al. Cell Mol Gastroenterol Hepatol. 2026;20(2):101661. doi: 10.1016/j.jcmgh.2025.101661. Epub 2025 Oct 18. Cell Mol Gastroenterol Hepatol. 2026. PMID: 41115530 Free PMC article. No abstract available.
Nintedanib ameliorates animal model of dermatitis.
Heo MJ, Lee C, Choi SY, Choi YM, An IS, Bae S, An S, Jung JH. Heo MJ, et al. Sci Rep. 2020 Mar 11;10(1):4493. doi: 10.1038/s41598-020-61424-1. Sci Rep. 2020. PMID: 32161331 Free PMC article.
Pediatric Ambulatory Central Line-Associated Bloodstream Infections.
Rinke ML, Heo M, Saiman L, Bundy DG, Rosenberg RE, DeLaMora P, Rabin B, Zachariah P, Mirhaji P, Ford WJH, Obaro-Best O, Drasher M, Klein E, Peshansky A, Oyeku SO. Rinke ML, et al. Among authors: heo m. Pediatrics. 2021 Jan;147(1):e20200524. doi: 10.1542/peds.2020-0524. Epub 2020 Dec 18. Pediatrics. 2021. PMID: 33386333
Longitudinal Interleaved Residency Training: A Consensus Definition.
Zeller TA, Beben K, Kong M, Martonffy I, Patterson S, Deas W, Heo M, Keister DM. Zeller TA, et al. Among authors: heo m. Fam Med. 2023 May;55(5):311-316. doi: 10.22454/FamMed.2023.378423. Epub 2023 Feb 21. Fam Med. 2023. PMID: 37310675 Free PMC article.
912 results